ResearcherGuangzhou Medical University Cancer HospitalNo recent work listed
Xiangliang Zhang
Matched on ORCID iD 0000-0001-6271-6619; OpenAlex author ID A5101647357. Sources: OpenAlex.
Their work
- Papers
- 3 (first author 0, last author 2)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 2
2015: 1 paper · 2016: none · 2017: none · 2018: none · 2019: none · 2020: 2 papers
Papers 3
- hsa_circ_001653 Implicates in the Development of Pancreatic Ductal Adenocarcinoma by Regulating MicroRNA-377-Mediated HOXC6 Axis. Last author DOI 10.1016/j.omtn.2019.12.028↗
- The Potential Therapeutic Role of Exosomal MicroRNA-520b Derived from Normal Fibroblasts in Pancreatic Cancer. Last author DOI 10.1016/j.omtn.2019.12.029↗
- MicroRNA-216a enhances the radiosensitivity of pancreatic cancer cells by inhibiting beclin-1-mediated autophagy. Co-author DOI 10.3892/or.2015.4078↗
Closest collaborators
The 2 strongest of 2 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Huijuan Shi · 3 shared papers, 2015–2020 · strength 0.33
- Paper hsa_circ_001653 Implicates in the Development of Pancreatic Ductal Adenocarcinoma by Regulating MicroRNA-377-Mediated H… DOI 10.1016/j.omtn.2019.12.028↗
- Paper The Potential Therapeutic Role of Exosomal MicroRNA-520b Derived from Normal Fibroblasts in Pancreatic Cancer. DOI 10.1016/j.omtn.2019.12.029↗
- Paper MicroRNA-216a enhances the radiosensitivity of pancreatic cancer cells by inhibiting beclin-1-mediated autophagy. DOI 10.3892/or.2015.4078↗
- Shuzhong Cui · 1 shared paper, 2015 · strength 0.06
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.